Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Value-Based Cancer Care

- PMLiVE

Successful product commercialisation: what can we learn from the rare disease setting?

Achieving launch success in an increasingly challenging commercial environment

- PMLiVE

Pfizer/BioNTech to offer COVID-19 vaccine to placebo recipients

Only those trial participants who are currently eligible under the EUA will be offered the vaccine

- PMLiVE

Sinopharm’s COVID-19 vaccine scores approval in China

Vaccine found to be 79% effective in top-line results

- PMLiVE

Pfizer, Sanofi and others set to increase US drug prices in 2021

Pressure from COVID-19 restrictions leads to drug price increases

- PMLiVE

First person in the UK given AstraZeneca/Oxford University COVID-19 vaccine

The vaccine can be stored at standard refrigerator temperatures

- PMLiVE

The Brexit clock is counting down and time is running out

What businesses need to know about post-Brexit immigration

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital, for this live Fireside Chat. Today, we are exploring a range of topics...

Impetus Digital

- PMLiVE

Launch leaders’ blog: what should launch leaders be measuring?

Challenging a few norms in our industry so we don’t become fixated on the wrong type of metrics

- PMLiVE

Treatment and prevention of cardiovascular disease

The potential of next generation omega-3 fatty acids

Impact of the Pandemic on Medical and Scientific Affairs

Dr. Shurjeel Choudhri, SVP and Head, Medical and Scientific Affairs at Bayer Canada, dives into a range of hot topics, from innovative digital technologies and beyond-the-pill medicine to the concept of patient-centricity....

Impetus Digital

- PMLiVE

Perfect partners

What are the key components for a successful partnership and how can that be achieved?

Roche Basel Switzerland

Roche gets EU approval for fixed-dose Herceptin/Perjeta combination

Treatment can be administered as an injection instead of an intravenous infusion

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links